Patents Represented by Attorney, Agent or Law Firm James Gregory Cullem
  • Patent number: 6982318
    Abstract: A class of motif-specific, context-independent antibodies that bind conserved signal transduction motifs, such as kinase consensus substrate motifs and protein-protein binding motifs, containing one or more modified amino acids, such as a phosphorylated amino acid, is provided. The antibodies bind a plurality of peptides or proteins that contain the modified motif. Context-independent antibodies specific for single modified residues, such as phosphothreonine, are also provided. Methods for producing and using such antibodies are provided.
    Type: Grant
    Filed: March 24, 2000
    Date of Patent: January 3, 2006
    Assignee: Cell Signaling Technology, Inc.
    Inventors: Michael J. Comb, Yi Tan
  • Patent number: 6441140
    Abstract: The present invention is related to a method for producing motif-specific, context-independent antibodies which are specific to at least one modified fixed amino acid residue in the context of variable surrounding amino acid or peptide sequences. The method is particularly useful in producing antibodies which recognize phosphorylated serine, threonine, and tyrosine, or acetylated lysine, as well as other modified amino acid-containing motifs of one or more amino acids.
    Type: Grant
    Filed: September 4, 1998
    Date of Patent: August 27, 2002
    Assignee: Cell Signaling Technology, Inc.
    Inventors: Michael J. Comb, Yi Tan
  • Patent number: 6300113
    Abstract: Substantially pure glycosidases capable for cleaving selected glycosidic bonds have been described including glycosidases isolated from Xanthomonas and recombinant glycosidases. Substrate specificity of isolated enzymes have been identified for GlcNac&bgr;1-X, Gal&agr;1-3R, Gal&agr;1-6R, Gal&bgr;1-3R, Fuc&agr;-2R, Fuc&agr;1-3R, Fuc&agr;1-4R, Man&agr;1-2R, Man&agr;1-3R, Man&agr;1-6R, Man&bgr;1-4R, Xyl&bgr;1-2R, Glc&bgr;1-4R, and Gal&bgr;1-4R providing improved capability for selectively cleaving a glycosidic linkage in a carbohydrate substrate and for forming modified carbohydrates.
    Type: Grant
    Filed: November 21, 1995
    Date of Patent: October 9, 2001
    Assignee: New England Biolabs Inc.
    Inventor: David Landry
  • Patent number: 6280992
    Abstract: In accordance with the present invention, there is provided a novel restriction endonuclease and its DNA obtainable from Helicobacter pylori J99 (NEB#1237), hereinafter referred to as “Hpy99I”, which endonuclease: (1) recognizes the nucleotide sequence 5′-CGWCG-3′ in a double-stranded DNA (wherein G represents guanine, C represents cytosine, A represents adenine, T represents thymine and W represents either A, or T); (2) cleaves double-stranded PhiX174 DNA to produce 8 fragments, including fragments of 3063, 629, 602, 447, 389, and 176 base pairs, and 2 fragments smaller than 100 base pairs.
    Type: Grant
    Filed: September 23, 1999
    Date of Patent: August 28, 2001
    Assignees: New England Biolabs, Inc., Vanderbilt University
    Inventors: Richard D. Morgan, Qing Xu
  • Patent number: 6258583
    Abstract: In accordance with the present invention, there is provided a novel restriction endonuclease and its DNA obtainable from Helicobacter pylori J188 (NEB#1174), hereinafter referred to as “Hpy188I”, which endonuclease: (1) recognizes the nucleotide sequence 5′-TCNGA-3′ in a double-stranded DNA molecule as shown below, 5′-TCN↓GA-3′ 3′-AG↑NCT-5′ (wherein G represents guanine, C represents cytosine, A represents adenine, T represents thymine and N represents either G, C, A, or T); (2) cleaves said sequence in the phosphodiester bonds between the N and G as indicated with the arrows; and (3) cleaves double-stranded PhiX174 DNA to produce 18 fragments, including fragments of 1331, 813, 572, 525, 396, 302, 293, 219 base pairs, and 10 fragments smaller than 200 base pairs.
    Type: Grant
    Filed: September 10, 1999
    Date of Patent: July 10, 2001
    Assignees: New England Biolabs, Inc., Vanderbilt University
    Inventors: Richard D. Morgan, Qing Xu
  • Patent number: 6245545
    Abstract: The present invention relates to the recombinant DNA which encodes the SwaI restriction endonuclease, modification methylase, and the production of SwaI restriction endonuclease from the recombinant DNA. Related expression vectors, pHKUV5 which features a strong, constitutive UV5 promoter without the Lac repressor binding site and pHKT7 which contains a powerful controllable T7 promoter and a low copy number origin of replication, are also disclosed.
    Type: Grant
    Filed: April 27, 1999
    Date of Patent: June 12, 2001
    Assignee: New England Biolabs, Inc.
    Inventors: Huimin Kong, Lauren S. Higgins, Michael A. Dalton